LONDON (UK) – Underpinned by gains for Wall Street futures, the European shares remained steady on Wednesday. It follows losses the day before on vaccine trials and a stimulus impasse, while the dollar too was stable.
In early trading the pan-European STOXX 600 was unchanged and markets in Frankfurt, London and Paris were steady to higher.
Markets had little direction as they grappled with “angst about vaccine/antibody delays, angst about rising covid cases in Europe, stalled US fiscal talks, stalled Brexit trade talks”, said Kit Juckes, macro strategist at Societe Generale.
Wall Street futures were up 0.4%, however, with US banks Goldman Sachs, Wells Fargo and Bank of America to report results on Wednesday, following above-estimate earnings from JPMorgan and Citigroup in the previous session.
Stock market losses began on Wall Street on Tuesday when Johnson & Johnson it was pausing a COVID-19 vaccine trial after a study participant suffered an unexplained illness.
Eli Lilly and Co later said it too had paused the clinical trial of its COVID-19 antibody treatment because of a safety concern, leading the US equity market to deepen losses.
J&J shares lost 2.3%, and Eli Lilly closed down nearly 3%.
Hopes for the passage of a new coronavirus relief package also faded as US House Speaker Nancy Pelosi rejected a $1.8 trillion relief proposal from the White House.
“US stimulus talks are still going nowhere, dimming the prospect of a new round of support this side of the election,” said Sydney-based NAB strategist Rodrigo Catril.
In addition, investors are watching tensions between the European Union and Britain after the EU demanded “substantive” movement on Tuesday on fisheries, dispute settlement and guarantees of fair competition in their talks on a post-Brexit trade deal.
Sterling declined the most among major currencies, down 0.4% against the euro, the dollar and yen. EU leaders will hold a summit in Brussels on Thursday and Friday to assess progress.